Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for O00194

Entry ID Method Resolution Chain Position Source
2F7S X-ray 270 A A/B 4-201 PDB
AF-O00194-F1 Predicted AlphaFoldDB

187 variants for O00194

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1246926975
CA402520864
2 T>A No ClinGen
gnomAD
rs562881530
CA8969490
2 T>I No ClinGen
1000Genomes
ExAC
gnomAD
rs183204493
CA8969493
3 D>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1472917397
CA402520896
4 G>R No ClinGen
TOPMed
gnomAD
rs750641827
CA8969495
5 D>H No ClinGen
ExAC
gnomAD
CA8969498
rs749423666
11 K>R No ClinGen
ExAC
gnomAD
CA8969499
rs768892870
14 A>V No ClinGen
ExAC
gnomAD
TCGA novel 15 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1333058724
CA402521105
16 G>E No ClinGen
gnomAD
rs772473656
CA8969502
16 G>R Variant assessed as Somatic; 9.422e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1333058724
CA402521103
16 G>V No ClinGen
gnomAD
rs772473656
CA402521101
16 G>W No ClinGen
ExAC
TOPMed
gnomAD
rs1290124969
CA402521126
20 V>M No ClinGen
TOPMed
gnomAD
rs1356060051
CA402521133
21 G>R No ClinGen
TOPMed
TCGA novel 22 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs187131898
CA402521186
27 Y>C No ClinGen
1000Genomes
gnomAD
rs187131898
CA300744253
27 Y>F No ClinGen
1000Genomes
gnomAD
rs764729616
CA8969508
28 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA8969509
rs752620773
29 Y>C No ClinGen
ExAC
gnomAD
rs1163674381
CA402521301
35 N>H No ClinGen
gnomAD
TCGA novel 38 F>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA300744258
rs867368280
40 T>I No ClinGen
gnomAD
CA402521394
rs1430487758
41 T>I No ClinGen
gnomAD
rs986190030
CA300744260
42 V>I No ClinGen
Ensembl
TCGA novel 43 G>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1445586376
CA402521442
45 D>N No ClinGen
TOPMed
CA8969515
rs766672373
47 R>P No ClinGen
ExAC
TOPMed
gnomAD
CA8969514
rs766672373
47 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs751512741
CA300744265
COSM1711382
47 R>W skin [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
rs989535601
CA300744271
48 E>G No ClinGen
TOPMed
gnomAD
rs755053322
CA8969516
49 K>I No ClinGen
ExAC
gnomAD
CA8969517
rs778920751
50 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs377291150
CA300744275
50 R>H No ClinGen
ESP
TOPMed
gnomAD
CA8969518
rs538294426
51 V>L No ClinGen
1000Genomes
ExAC
gnomAD
rs757557745
CA8969540
52 V>F No ClinGen
ExAC
TOPMed
gnomAD
COSM709345
rs757557745
CA402521935
52 V>I lung Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1038468355
CA300744572
53 Y>C No ClinGen
TOPMed
rs781592469
CA8969541
53 Y>D No ClinGen
ExAC
gnomAD
CA402521965
rs1320351664
54 N>S No ClinGen
gnomAD
rs779474355
CA8969542
55 A>S No ClinGen
ExAC
gnomAD
rs1323494794
CA402521986
56 Q>* No ClinGen
gnomAD
rs865964184
CA300744574
57 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
COSM563720
CA8969544
rs775038590
57 G>R lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs529722142
CA8969545
58 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs529722142
CA300744576
58 P>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1346540708
CA402522037
60 G>E No ClinGen
TOPMed
CA8969549
rs767419104
64 K>R No ClinGen
ExAC
gnomAD
CA300744585
rs1025566149
65 A>E No ClinGen
Ensembl
CA8969551
rs200080884
66 F>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs200080884
CA8969550
66 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA402522149
rs1598989345
68 V>G No ClinGen
Ensembl
CA8969552
rs765328507
69 H>Y No ClinGen
ExAC
TOPMed
gnomAD
CA300744590
rs746934226
70 L>F No ClinGen
TOPMed
gnomAD
CA402522194
rs1199734462
72 L>F No ClinGen
gnomAD
CA402522193
rs1199734462
72 L>V No ClinGen
gnomAD
rs752994920
CA8969553
76 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA300744593
rs752994920
76 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA402522276
rs1413085158
78 Q>* No ClinGen
gnomAD
CA8969556
rs370613157
80 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs376553954
CA8969555
80 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA402523050
rs1340082952
82 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs367644272
CA8969576
COSM1287503
82 R>W autonomic_ganglia [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA8969577
rs767959071
83 S>G No ClinGen
ExAC
gnomAD
rs750955967
CA8969578
85 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA402523097
rs1340086222
86 T>I No ClinGen
gnomAD
CA8969580
rs780529654
88 F>V No ClinGen
ExAC
CA8969582
rs754703077
89 F>S No ClinGen
ExAC
gnomAD
TCGA novel 91 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8969586
rs9966265
92 A>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8969585
VAR_051714
rs9966265
92 A>T No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs867951640
CA300745536
93 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA402523185
rs1305888809
93 M>T No ClinGen
TOPMed
rs770617882
CA8969588
93 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA300745538
rs868101938
94 G>S No ClinGen
Ensembl
CA402523221
rs1464532457
96 L>I No ClinGen
TOPMed
gnomAD
rs1464532457
CA402523223
96 L>V No ClinGen
TOPMed
gnomAD
rs1433553560
CA402523255
98 M>T No ClinGen
TOPMed
CA402523277
rs1397596051
99 F>L No ClinGen
gnomAD
CA402523274
rs1402563085
99 F>S No ClinGen
gnomAD
CA402523306
rs1346285878
102 T>A No ClinGen
TOPMed
CA8969593
rs761837069
105 Q>H No ClinGen
ExAC
gnomAD
CA8969592
rs774575893
105 Q>L No ClinGen
ExAC
gnomAD
CA402523359
rs1298340426
106 S>N No ClinGen
TOPMed
rs767584601
CA8969595
106 S>R No ClinGen
ExAC
gnomAD
CA300745546
rs201355784
107 F>L No ClinGen
Ensembl
CA402523387
rs1369753377
108 L>F No ClinGen
TOPMed
gnomAD
CA8969596
rs761314668
110 V>I No ClinGen
ExAC
gnomAD
CA402523406
rs761314668
110 V>L No ClinGen
ExAC
gnomAD
TCGA novel 116 Q>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA8969616
rs777037766
116 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA402524473
rs1487335776
118 Q>K No ClinGen
TOPMed
gnomAD
rs1249539796
CA402524526
121 A>G No ClinGen
TOPMed
gnomAD
CA402524533
rs1253089421
122 Y>F No ClinGen
TOPMed
gnomAD
rs1253089421
CA402524532
122 Y>S No ClinGen
TOPMed
gnomAD
rs759912904
CA8969617
127 D>H No ClinGen
ExAC
gnomAD
rs1267929626
CA402524608
127 D>V No ClinGen
gnomAD
CA402524628
rs1457602591
128 I>M No ClinGen
TOPMed
gnomAD
CA8969618
rs765711010
128 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1156664609
CA402524619
128 I>V No ClinGen
TOPMed
gnomAD
CA8969619
rs372053847
129 V>I No ClinGen
ESP
ExAC
gnomAD
CA8969621
rs763664942
131 I>F No ClinGen
ExAC
TOPMed
gnomAD
CA402524662
rs1368902719
131 I>T No ClinGen
gnomAD
rs1287005983
CA402524738
137 L>V No ClinGen
gnomAD
rs77350395
CA8969623
138 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs77350395
CA402524753
138 P>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8969624
rs781142576
139 D>A No ClinGen
ExAC
gnomAD
rs1482845008
CA402524757
139 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs150505850
CA8969625
140 Q>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8969626
rs755843368
141 R>K No ClinGen
ExAC
gnomAD
rs755843368
CA402524787
141 R>T No ClinGen
ExAC
gnomAD
CA402524824
rs1225110886
143 V>I No ClinGen
TOPMed
rs1265574999
CA402524844
144 N>S No ClinGen
gnomAD
rs184898936
CA300746243
146 R>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8969628
rs184898936
146 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs749772540
CA8969627
146 R>W No ClinGen
ExAC
TOPMed
gnomAD
CA8969629
rs772332104
147 Q>H No ClinGen
ExAC
gnomAD
CA402524895
rs1184128382
148 A>D Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
rs773331315
CA8969630
148 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA402524897
rs1184128382
148 A>V No ClinGen
TOPMed
gnomAD
rs148221800
CA8969633
149 R>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8969634
rs148221800
149 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA8969631
rs1410433534
149 R>W No ClinGen
TOPMed
gnomAD
CA8969637
rs770277500
151 L>Q No ClinGen
ExAC
TOPMed
gnomAD
rs760180262
CA402524923
151 L>V No ClinGen
ExAC
gnomAD
CA300746254
rs776035357
152 A>D No ClinGen
ExAC
TOPMed
gnomAD
CA8969638
rs776035357
152 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA402524933
rs1306664518
152 A>S No ClinGen
gnomAD
rs1306664518
CA402524930
152 A>T No ClinGen
gnomAD
CA8969639
rs190794224
153 D>E No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA8969640
rs763749981
154 K>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 154 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs751198891
CA8969641
155 Y>C No ClinGen
ExAC
gnomAD
CA8969642
rs761316323
156 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA402525069
rs1276454890
157 I>V No ClinGen
TOPMed
gnomAD
CA402525083
rs1210615856
158 P>A No ClinGen
gnomAD
rs1243942301
CA402525112
160 F>S No ClinGen
gnomAD
rs1277569049
CA402525121
161 E>* No ClinGen
TOPMed
CA402525147
rs768902755
163 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA8969658
rs768902755
163 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs773994833
CA8969659
164 A>T No ClinGen
ExAC
gnomAD
rs767025431
CA8969661
166 T>A No ClinGen
ExAC
gnomAD
rs1331645296
CA402525200
168 Q>R No ClinGen
TOPMed
rs1414235076
CA402525222
170 V>M No ClinGen
gnomAD
CA402525263
rs1322861195
173 A>P No ClinGen
TOPMed
rs1335359282
CA402525275
174 V>I No ClinGen
gnomAD
CA402525305
rs1321222457
176 T>A No ClinGen
TOPMed
CA402525313
rs1475732197
176 T>I No ClinGen
gnomAD
rs1187982493
CA402525380
182 M>V No ClinGen
gnomAD
CA8969664
rs760204134
183 K>R No ClinGen
ExAC
gnomAD
rs766267582
CA8969665
184 R>* No ClinGen
ExAC
gnomAD
CA402525767
rs753780291
184 R>L No ClinGen
ExAC
TOPMed
gnomAD
COSM225061
rs753780291
CA8969666
184 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine skin [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 185 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA402525792
rs1411357783
186 E>G No ClinGen
gnomAD
rs73956736
CA300746490
187 Q>E No ClinGen
1000Genomes
TOPMed
CA8969668
rs778632811
187 Q>H No ClinGen
ExAC
gnomAD
rs754744114
CA8969667
187 Q>R No ClinGen
ExAC
CA300746493
rs1004828409
188 C>R No ClinGen
TOPMed
gnomAD
rs1004828409
CA402525809
188 C>S No ClinGen
TOPMed
gnomAD
CA300746494
rs753930771
188 C>Y No ClinGen
Ensembl
rs751803591
CA8969669
190 E>Q No ClinGen
ExAC
gnomAD
rs757459786
CA8969670
191 K>N No ClinGen
ExAC
gnomAD
rs745893504
CA8969672
192 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs553510372
CA300746500
193 Q>E No ClinGen
Ensembl
CA8969673
rs201695355
193 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA402525918
rs1165901346
195 P>H No ClinGen
TOPMed
gnomAD
rs1165901346
CA402525924
195 P>L No ClinGen
TOPMed
gnomAD
rs749824892
CA8969675
195 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA8969676
rs769049294
196 D>V No ClinGen
ExAC
TOPMed
gnomAD
rs1177806440
CA402525975
198 V>A No ClinGen
gnomAD
CA402525988
rs1599000348
199 N>S No ClinGen
Ensembl
rs867508011
CA300746506
201 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA8969677
rs774621967
201 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA8969678
rs747817691
203 S>F No ClinGen
ExAC
gnomAD
rs1157892324
CA402526087
206 L>S No ClinGen
gnomAD
rs771580227
CA8969679
207 D>N No ClinGen
ExAC
gnomAD
TCGA novel 209 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1437030743
CA402526164
211 P>L No ClinGen
gnomAD
rs765888700
CA8969682
212 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA8969684
rs759459653
213 E>V No ClinGen
ExAC
gnomAD
CA8969686
CA300746518
rs374063750
215 K>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA300746515
rs994620598
215 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
CA402526229
rs1351760927
216 C>Y No ClinGen
gnomAD
CA402526237
rs1206966109
217 I>F No ClinGen
TOPMed
gnomAD
rs1599000450
CA402526247
217 I>M No ClinGen
Ensembl
rs1206966109
CA402526238
217 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 218 C>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

No associated diseases with O00194

1 regional properties for O00194

Type Name Position InterPro Accession
domain Small GTP-binding protein domain 8 - 177 IPR005225

Functions

Description
EC Number 3.6.5.2 Acting on GTP; involved in cellular and subcellular movement
Subcellular Localization
  • Membrane; Lipid-anchor
  • Late endosome
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

15 GO annotations of cellular component

Name Definition
anchored component of synaptic vesicle membrane The component of the synaptic vesicle membrane consisting of the gene products that are tethered to the membrane only by a covalently attached anchor, such as a lipid group that is embedded in the membrane. Gene products with peptide sequences that are embedded in the membrane are excluded from this grouping.
apical plasma membrane The region of the plasma membrane located at the apical end of the cell.
axon cytoplasm Any cytoplasm that is part of a axon.
exocytic vesicle A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis.
extracellular exosome A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
Golgi stack The set of thin, flattened membrane-bounded compartments, called cisternae, that form the central portion of the Golgi complex. The stack usually comprises cis, medial, and trans cisternae; the cis- and trans-Golgi networks are not considered part of the stack.
late endosome A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
melanosome A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells.
multivesicular body membrane The lipid bilayer surrounding a multivesicular body.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
platelet dense granule membrane The lipid bilayer surrounding the platelet dense granule.
secretory granule A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules.
trans-Golgi network transport vesicle A vesicle that mediates transport between the trans-Golgi network and other parts of the cell.
zymogen granule membrane The lipid bilayer surrounding a zymogen granule.

6 GO annotations of molecular function

Name Definition
G protein activity A molecular function regulator that cycles between active GTP-bound and inactive GDP-bound states. In its active state, binds to a variety of effector proteins to regulate cellular processes. Intrinsic GTPase activity returns the G protein to its GDP-bound state. The return to the GDP-bound state can be accelerated by the action of a GTPase-activating protein (GAP).
GDP binding Binding to GDP, guanosine 5'-diphosphate.
GTP binding Binding to GTP, guanosine triphosphate.
GTPase activity Catalysis of the reaction: GTP + H2O = GDP + H+ + phosphate.
myosin V binding Binding to a class V myosin; myosin V is a dimeric molecule involved in intracellular transport.
protein domain specific binding Binding to a specific domain of a protein.

6 GO annotations of biological process

Name Definition
anterograde axonal protein transport The directed movement of proteins along microtubules from the cell body toward the cell periphery in nerve cell axons.
exocytosis A process of secretion by a cell that results in the release of intracellular molecules (e.g. hormones, matrix proteins) contained within a membrane-bounded vesicle. Exocytosis can occur either by full fusion, when the vesicle collapses into the plasma membrane, or by a kiss-and-run mechanism that involves the formation of a transient contact, a pore, between a granule (for exemple of chromaffin cells) and the plasma membrane. The latter process most of the time leads to only partial secretion of the granule content. Exocytosis begins with steps that prepare vesicles for fusion with the membrane (tethering and docking) and ends when molecules are secreted from the cell.
multivesicular body sorting pathway A vesicle-mediated transport process in which transmembrane proteins are ubiquitylated to facilitate their entry into luminal vesicles of multivesicular bodies (MVBs); upon subsequent fusion of MVBs with lysosomes or vacuoles, the cargo proteins are degraded.
positive regulation of exocytosis Any process that activates or increases the frequency, rate or extent of exocytosis.
synaptic vesicle endocytosis A vesicle-mediated transport process, in which the synaptic vesicle membrane constituents are retrieved from the presynaptic membrane on the axon terminal after neurotransmitter secretion by exocytosis. Synaptic vesicle endocytosis can occur via clathrin-dependent and clathrin-independent mechanisms.
vesicle-mediated transport A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane.

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q8HZJ5 RAB27B Ras-related protein Rab-27B Bos taurus (Bovine) PR
Q1HE58 RAB27A Ras-related protein Rab-27A Canis lupus familiaris (Dog) (Canis familiaris) PR
Q15771 RAB30 Ras-related protein Rab-30 Homo sapiens (Human) PR
P51159 RAB27A Ras-related protein Rab-27A Homo sapiens (Human) PR
Q9BZG1 RAB34 Ras-related protein Rab-34 Homo sapiens (Human) PR
O95755 RAB36 Ras-related protein Rab-36 Homo sapiens (Human) PR
Q9ERI2 Rab27a Ras-related protein Rab-27A Mus musculus (Mouse) PR
Q99P58 Rab27b Ras-related protein Rab-27B Mus musculus (Mouse) PR
Q4LE85 RAB27A Ras-related protein Rab-27A Sus scrofa (Pig) PR
P23640 Rab27a Ras-related protein Rab-27A Rattus norvegicus (Rat) PR
Q99P74 Rab27b Ras-related protein Rab-27B Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MTDGDYDYLI KLLALGDSGV GKTTFLYRYT DNKFNPKFIT TVGIDFREKR VVYNAQGPNG
70 80 90 100 110 120
SSGKAFKVHL QLWDTAGQER FRSLTTAFFR DAMGFLLMFD LTSQQSFLNV RNWMSQLQAN
130 140 150 160 170 180
AYCENPDIVL IGNKADLPDQ REVNERQARE LADKYGIPYF ETSAATGQNV EKAVETLLDL
190 200 210
IMKRMEQCVE KTQIPDTVNG GNSGNLDGEK PPEKKCIC